Lv1
90 积分 2024-11-12 加入
D3S-001 in advanced solid tumors with KRASG12C mutations: a phase 1 trial
3天前
已完结
Anti-BCMA/GPRC5D bispecific CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, single-centre, phase 1 trial
1个月前
已关闭
Anti-BCMA/GPRC5D bispecific CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, single-centre, phase 1 trial
1个月前
已完结
Phase I Trial of MCARH109, a G Protein–Coupled Receptor Class C Group 5 Member D (GPRC5D)–Targeted Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma: An Updated Analysis
1个月前
已完结
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease
皖公网安备34019202002308
